Advertise With UsAdvertise on our extensive network of industry websites and newsletters.
Get the PBR newsletterSign up to our free email to get all the latest PBR
news.EC approves new indication for Boehringer’s nintedanib in pulmonary fibrosis
The EC has approved new indication for Boehringer’s nintedanib in pulmonary fibrosis. (Credit: Madras150)
The EC has approved new indication for Boehringer’s nintedanib in pulmonary fibrosis. (Credit: Madras150)